An update on allergic Rhinitis treatment was held at Hotel Le Meridian Delhi on July 8,2007.It was attended by nearly 100 prominent ENT Surgeons of North India .The speaker was Dr Anjuli S. Nayak from USA. The talk was elaborate touching various aspects of allergy. It was stressed that a sizable population of adults and children are effected by this debilitating condition and the incidence is on the rise. In India ,26% of population suffers from allergic Rhinitis.
Using existing studies as EBM,the speaker concluded that Loratidine is an effective line of treatment and its safe and non sedating with convenience of once a day dose. The talk was sponsored by Fulford (India) Limited (Alaspan 10mg )
If someone could post a summary of the transactions in "Allergi Rhinitis Update" it would have been useful to a lot of people who are not able to attend such confernences.
ReplyDeleteOr even summary of one or two key talks is enough.
Best,
Dr.Thomas Antony
LM 850
Aden, Rep of Yemen